David K Gaffney

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. doi request reprint Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix
    O Kenneth Macdonald
    Department of Radiation Oncology, Mayo Clinic, Desk R, 200 First St SW, Rochester, MN 55905, USA
    Am J Clin Oncol 32:411-6. 2009
  2. pmc Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies
    Deborah E Citrin
    Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Radiat Oncol 7:64. 2012
  3. doi request reprint Advances in clinical research in gynecologic radiation oncology: an RTOG symposium
    David Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA
    Int J Gynecol Cancer 22:667-74. 2012
  4. ncbi request reprint A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128
    David K Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 67:104-9. 2007
  5. doi request reprint Patterns of care for radiotherapy in vulvar cancer: a Gynecologic Cancer Intergroup study
    David K Gaffney
    Radiation Therapy Oncology Group, Department of Radiation Oncology, Huntsman Cancer Hospital, 1950 Circle of Hope, Rm 1570, Salt Lake City, UT 84112, USA
    Int J Gynecol Cancer 19:163-7. 2009
  6. ncbi request reprint Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG)
    David K Gaffney
    Radiation Therapy Oncology Group, Salt Lake City, UT 84112, USA
    Int J Radiat Oncol Biol Phys 68:485-90. 2007
  7. ncbi request reprint Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128
    David K Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 69:111-7. 2007
  8. doi request reprint Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
    Marcus A Crosby
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, USA
    Am J Clin Oncol 33:364-9. 2010
  9. pmc Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
    Lori J Pierce
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive Room 4308, Ann Arbor, MI 48109, USA
    Breast Cancer Res Treat 121:389-98. 2010
  10. ncbi request reprint Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Gynecol Oncol 99:415-21. 2005

Detail Information

Publications51

  1. doi request reprint Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix
    O Kenneth Macdonald
    Department of Radiation Oncology, Mayo Clinic, Desk R, 200 First St SW, Rochester, MN 55905, USA
    Am J Clin Oncol 32:411-6. 2009
    ..We queried a large database to analyze the importance of number of positive LN and histology in relation to survival after radical hysterectomy and lymphadenectomy...
  2. pmc Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies
    Deborah E Citrin
    Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Radiat Oncol 7:64. 2012
    ..The purpose of this pilot study was to determine the feasibility of measuring local salivary cytokine levels using buccal sponges in patients receiving chemo-radiation for head and neck malignancies...
  3. doi request reprint Advances in clinical research in gynecologic radiation oncology: an RTOG symposium
    David Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA
    Int J Gynecol Cancer 22:667-74. 2012
    ....
  4. ncbi request reprint A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128
    David K Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 67:104-9. 2007
    ..To determine treatment-related acute toxicity rates in patients with locally advanced cervical cancer treated by oral celecoxib, i.v. cisplatin and 5-FU, and concurrent pelvic radiation therapy...
  5. doi request reprint Patterns of care for radiotherapy in vulvar cancer: a Gynecologic Cancer Intergroup study
    David K Gaffney
    Radiation Therapy Oncology Group, Department of Radiation Oncology, Huntsman Cancer Hospital, 1950 Circle of Hope, Rm 1570, Salt Lake City, UT 84112, USA
    Int J Gynecol Cancer 19:163-7. 2009
    ..This study aimed to describe radiotherapeutic practice in the treatment of vulvar cancer in member study groups of the Gynecologic Cancer Intergroup (GCIG)...
  6. ncbi request reprint Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG)
    David K Gaffney
    Radiation Therapy Oncology Group, Salt Lake City, UT 84112, USA
    Int J Radiat Oncol Biol Phys 68:485-90. 2007
    ..The aim of this study was to describe radiotherapeutic practice of the treatment of cervical cancer in member groups of the Gynecologic Cancer Intergroup (GCIG)...
  7. ncbi request reprint Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128
    David K Gaffney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 69:111-7. 2007
    ..To determine the efficacy and patterns of initial failure for oral celecoxib, intravenous cisplatin, and 5-fluorouracil and concurrent pelvic radiotherapy in patients with locally advanced cancer of the cervix...
  8. doi request reprint Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
    Marcus A Crosby
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, USA
    Am J Clin Oncol 33:364-9. 2010
    ..We evaluated the effect of adjuvant EBRT and combined EBRT + BT on overall survival and relative survival within a large US population database...
  9. pmc Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
    Lori J Pierce
    Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive Room 4308, Ann Arbor, MI 48109, USA
    Breast Cancer Res Treat 121:389-98. 2010
    ..However, women undergoing BCT have an elevated risk of a second in-breast event that is significantly reduced in the presence of chemotherapy. Contralateral breast cancer events are very common...
  10. ncbi request reprint Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Gynecol Oncol 99:415-21. 2005
    ..To investigate prognostic significance of and correlations between HER1 (EGFR), HER2 (c-erb-B2), HER3 (c-erb-B3), HER4 (c-erb-B4), and phosphorylated Akt (P-Akt) in patients treated with radiation for cervical carcinoma...
  11. ncbi request reprint Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial
    Aaron H Wolfson
    Department of Radiation Oncology, University of Miami Miller School of Medicine, 1475 NW 12th Avenue, D 31, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 70:111-7. 2008
    ....
  12. ncbi request reprint Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women
    O Kenneth Macdonald
    Department of Radiation Oncology, Huntsman Cancer Hospital at the University of Utah, Salt Lake City, UT 84112 5560, USA
    Gynecol Oncol 103:661-6. 2006
    ..The primary objective of this analysis was to evaluate the survival outcomes of women with early-stage endometrial cancer treated with surgery alone or surgery followed by RT...
  13. ncbi request reprint An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer
    Brandon M Barney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Brachytherapy 6:201-6. 2007
    ..Secondary endpoints included assessment of acute and late treatment toxicity, medication requirements, and charges related to the HDR-BT simulation and procedure...
  14. ncbi request reprint The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant
    Merideth M M Wendland
    Department of Radiation Oncology, Huntsman Cancer Hospital and the University of Utah, Salt Lake City, Utah 84112, USA
    Am J Clin Oncol 30:156-62. 2007
    ..We examined the role of involved field radiation therapy (IFRT) in this setting...
  15. ncbi request reprint Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program
    O Kenneth Macdonald
    Department of Radiation Oncology, Huntsman Cancer Hospital at the University of Utah, Salt Lake City, Utah 84112 5560, USA
    Cancer 107:2127-33. 2006
    ..The current study used a large population database to determine prognostic factors that predict cause-specific survival (CSS)...
  16. ncbi request reprint Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, Salt Lake City, Utah 99202, USA
    Cancer 110:2092-100. 2007
    ....
  17. ncbi request reprint Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis
    Christopher M Lee
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84132, USA
    Gynecol Oncol 93:209-14. 2004
    ..Comparative evaluations of manual and automated immunohistochemical imaging systems for HER2neu and EGFR expression were made...
  18. ncbi request reprint Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 107:2392-400. 2006
    ..The optimal treatment for men with early stage prostate cancer remains undefined. Survival of such patients after surgery, brachytherapy, or no definitive therapy was investigated specifically to determine the impact of age at diagnosis...
  19. doi request reprint Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy
    Christopher J Anker
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84112 5560, USA
    Int J Radiat Oncol Biol Phys 76:704-12. 2010
    ..To evaluate local control and toxicity by use of a method of adaptive cervical brachytherapy (ACB)...
  20. doi request reprint Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer
    Amol J Ghia
    Huntsman Cancer Institute, University of Utah, USA
    Gynecol Oncol 119:411-6. 2010
    ..The objective of this study is to perform a patterns of care analysis for post-hysterectomy patients with node positive (LN+) or parametria positive cervical cancer...
  21. doi request reprint Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions
    Aaron E Wagner
    Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
    Gynecol Oncol 129:517-21. 2013
    ..This study was designed to investigate the impact of size within stage I-IIIB cervical carcinoma, and to validate these changes...
  22. doi request reprint Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis
    Amol J Ghia
    Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
    Int J Gynecol Cancer 21:378-84. 2011
    ..We sought to describe the utilization rate of CRT and evaluate the potential survival benefit of CRT over radiotherapy alone in VC...
  23. ncbi request reprint The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease
    Merideth M M Wendland
    Department of Radiation Oncology, Huntsman Cancer Hospital and the University of Utah, Salt Lake City, UT, USA
    Am J Clin Oncol 29:189-95. 2006
    ..This study sought to determine if involved field radiation therapy (IFRT) in this setting improves patient outcomes...
  24. doi request reprint A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations
    Aaron P Brown
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84112, USA
    Int J Radiat Oncol Biol Phys 78:127-35. 2010
    ..To examine the risk of subsequent primary malignancies (SPMs) in women diagnosed with endometrial cancer...
  25. doi request reprint Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix
    Jergin Chen
    Department of Radiation Oncology, Huntsman Cancer Institute, Salt Lake City, Utah 84112, USA
    Obstet Gynecol 111:1394-402. 2008
    ..To compare the incidence, mortality, and presentation of small cell carcinoma of the cervix with other histologies...
  26. doi request reprint Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma
    Jonathan D Tward
    University of Utah and Huntsman Cancer Institute, Salt Lake City, UT, USA
    Cancer J 15:87-92. 2009
    ..To evaluate overall and relapse-free survival (RFS) in patients with nonmycosis fungoides (non-MF) primary cutaneous lymphoma (PCL)...
  27. doi request reprint Transient dephosphorylation of p53 serine 376 as an early response to ionizing radiation
    Raymond L Warters
    Department of Radiation Oncology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Radiat Res 171:725-34. 2009
    ..The data suggest that dephosphorylation of serine 376 on constitutive nuclear p53 is a sensitive and early signaling event in the response of cells to DNA damage induced by ionizing radiation...
  28. doi request reprint Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?
    Brandon Barney
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT 84112, USA
    Int J Gynecol Cancer 19:1232-8. 2009
    ..The roles of radiation therapy (RT) and lymphadenectomy (LAD) remain unclear. Using a large population database, we retrospectively evaluated the addition of RT and LAD to surgery for survival impact...
  29. ncbi request reprint The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma
    D Clayton Smith
    Department of Radiation Oncology, Huntsman Cancer Hospital at the University of Utah, UT 84119, USA
    Radiother Oncol 88:227-32. 2008
    ..Uterine carcinosarcoma is an aggressive neoplasm and the benefit of adjuvant radiation therapy (RT) is unclear. This retrospective study analyzes the influence of RT on survival using a large population database...
  30. ncbi request reprint Time interval to the development of breast carcinoma after treatment for Hodgkin disease
    Merideth M M Wendland
    Department of Radiation Oncology, The Huntsman Cancer Institute, Salt Lake City, Utah, USA
    Cancer 101:1275-82. 2004
    ..Women with Hodgkin disease (HD) who received mantle irradiation had an increased risk of developing breast carcinoma. The authors examined the influence of radiotherapy on the time interval to the development of breast carcinoma...
  31. ncbi request reprint Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Hospital and University of Utah Medical Center, Salt Lake City 84112 5560, USA
    JAMA 295:389-97. 2006
    ..The benefit of adjuvant radiation therapy (RT) in stage I endometrial adenocarcinoma remains controversial despite several phase 3 trials...
  32. doi request reprint Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology
    Brandi R Page
    Department of Radiation Oncology, University of Utah Huntsman Cancer Hospital, Salt Lake City, UT 84112, USA
    Int J Gynecol Cancer 22:593-8. 2012
    ..Different histologies were examined in a large population database. The FIGO 1988 and 2009 staging systems were compared for stage at presentation, differences in patient populations, and disease-specific survival (DSS)...
  33. doi request reprint Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Ellen W Cooke
    Department of Radiation Oncology, University of Utah Huntsman Cancer Hospital, Salt Lake City, Utah 84112, USA
    Cancer 117:4231-7. 2011
    ..The objective of this study was to compare survival outcomes for patients who were staged according to the 1988 FIGO staging system versus the 2009 FIGO staging system...
  34. ncbi request reprint Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy
    John K O'Connor
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 58:1034-40. 2004
    ..To evaluate the relationship between cyclooxygenase-2 (COX-2) expression and pathologic features and outcome in invasive breast cancer...
  35. doi request reprint Survival analysis of endometrial cancer patients with positive lymph nodes
    Aaron P Brown
    Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
    Int J Gynecol Cancer 23:861-8. 2013
    ..This study investigates how tumor characteristics and adjuvant treatments influence overall survival (OS) in stage IIIC patients...
  36. pmc Differential gene expression in primary human skin keratinocytes and fibroblasts in response to ionizing radiation
    Raymond L Warters
    Department of Radiation Oncology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Radiat Res 172:82-95. 2009
    ..Both Q-PCR and Western blot analysis experiments validated these transcription changes. Our results are consistent with changes in the expression of p53 target genes as indicating the magnitude of cell responses to ionizing radiation...
  37. ncbi request reprint The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
    Jonathan D Tward
    Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112 5560, USA
    Cancer 107:108-15. 2006
    ..Survivors of non-Hodgkin lymphoma (NHL) are at increased risk for developing secondary malignancies. For the current study, the authors quantitated this risk in a group of NHL survivors over 30 years of follow-up...
  38. ncbi request reprint Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
    Lori J Pierce
    Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI 48109 0010, USA
    J Clin Oncol 24:2437-43. 2006
    ..We compared the outcome of breast-conserving surgery and radiotherapy in BRCA1/2 mutation carriers with breast cancer versus that of matched sporadic controls...
  39. ncbi request reprint Rapid involution and mobility of carcinoma of the cervix
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, 50 N Medical Drive, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 58:625-30. 2004
    ..These data have implications for conformal or intensity modulated radiation therapy boost to the cervix...
  40. ncbi request reprint Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines
    Christopher M Lee
    Department of Radiation Oncology, University of Utah School of Medicine and Huntsman Cancer Hospital, Salt Lake City, Utah, USA
    Clin Cancer Res 12:250-6. 2006
    ..We evaluated the radiosensitizing effect of PI3K inhibition by LY294002 on clonogenic survival, growth characteristics, and gene expression in cervical cancer cell lines (HeLa and CaSki)...
  41. ncbi request reprint Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium?
    O Kenneth Macdonald
    Department of Radiation Oncology, Huntsman Cancer Hospital at the University of Utah, 1950 Circle of Hope, Salt Lake City, UT 84112 5560, USA
    Gynecol Oncol 99:730-5. 2005
    ..To evaluate treatment outcomes in women with early-stage endometrial cancer (FIGO IA, IB, IC, or IIA) surgically managed by a general gynecologist (GYN) or a gynecologic oncologist (GYO)...
  42. ncbi request reprint Electron arc irradiation of the postmastectomy chest wall in locally recurrent and metastatic breast cancer
    David K Gaffney
    Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84132, USA
    Am J Clin Oncol 26:241-6. 2003
    ....
  43. ncbi request reprint Diminished survival in patients with inner versus outer quadrant breast cancers
    David K Gaffney
    Department of Radiation Oncology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84132, USA
    J Clin Oncol 21:467-72. 2003
    ..To evaluate the role of breast tumor location on survival in patients with breast cancer...
  44. doi request reprint Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients?
    Richard V Hymas
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA
    Int J Radiat Oncol Biol Phys 83:519-24. 2012
    ..This retrospective study was undertaken to determine the cancer yield mammography during the first 2 years after BCT...
  45. doi request reprint Role of radiotherapy treatment of uterine sarcoma
    Sagus Sampath
    Department of Radiation Oncology, University of New Mexico, USA
    Best Pract Res Clin Obstet Gynaecol 25:761-72. 2011
    ..As distant failure rates decrease with improvements in systemic therapies, there may be a broader indication for adjuvant radiotherapy...
  46. ncbi request reprint Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?
    Jergin Chen
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 58:1474-9. 2004
    ..To determine whether the risk of secondary breast cancer after radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT around time of pregnancy...
  47. ncbi request reprint Is simulation necessary for each high-dose-rate tandem and ovoid insertion in carcinoma of the cervix?
    Nathan D Jones
    Department of Radiation Oncology and Huntsman Cancer Institute, University of Utah Medical Center, 1950 Circle of Hope, Salt Lake City, UT 84112, USA
    Brachytherapy 3:120-4. 2004
    ..To evaluate the dose variation in high-dose-rate (HDR) intracavitary brachytherapy for cancer of the cervix when treatment planning is performed prior to each applicator insertion versus when the initial plan is used for each treatment...
  48. ncbi request reprint Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
    David K Gaffney
    Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84132, USA
    Int J Radiat Oncol Biol Phys 56:922-8. 2003
    ..the natural history of the disease, (2). response to radiotherapy (RT), and (3). potential for new therapeutic strategies...
  49. ncbi request reprint Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy
    Christopher M Lee
    Department of Radiation Oncology, Huntsman Cancer Institute and University of Utah, Salt Lake City, UT 84132, USA
    Am J Hematol 78:151-2. 2005
    ..Radiation therapy has proven to be an effective modality for treatment of this rare radiosensitive disease...
  50. ncbi request reprint Facilitation of radiotherapeutic error by computerized record and verify systems
    Gregory A Patton
    Northwest Cancer Specialists, PC, Portland, OR 97227, USA
    Int J Radiat Oncol Biol Phys 56:50-7. 2003
    ..To examine the impact of computerized record and verify (R&V) systems on types of radiotherapeutic error...
  51. ncbi request reprint Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer
    John K O'Connor
    Radiation Oncology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA
    Int J Radiat Oncol Biol Phys 65:1411-5. 2006
    ..The purpose of this study was to evaluate the relationship between Topo II alpha expression and survival in patients with invasive breast cancer...